Book Building
₹ 401.54 cr
₹ 460
30
₹ 13,800.00
MumbaiNSE
04-Aug-2021
06-Aug-2021
16-Aug-2021
The Shares of Windlas Biotech Ltd have now been listed.
Initial Public Offer of 8,729,023* equity shares of face value of Rs.5 each (equity shares) of Windlas Biotech Limited (company Rs.455 per equity share) aggregating to Rs.401.54 Crores (the offer) comprising a fresh issue of 3,586,956* equity shares aggregating to Rs.165 Crores (the fresh issue) and an offer for sale of 5,142,067* equity shares, comprising of 1,136,000* equity shares aggregating to Rs.52.26* Crores by Vimla Windlass (the individual selling shareholder) and 4,006,067* equity shares aggregating to Rs.184.28* Crores by Tano India Private Equity Fund II (the investor selling shareholder, and collectively with the individual selling shareholder, the selling shareholders, and such equity shares, the offered shares) aggregating to Rs.236.54 Crores (the offer for sale). The offer constitutes 40.05% of the post-offer paid-up equity share capital of the Company. The face value of equity shares is Rs.5 each. The offer price is Rs.460 per equity share and is 92 times the face value of the equity shares. *subject to finalisation of the basis of allotment.
Purchase of Equipment required for (i) Capacity Expansion of the existing facility at the Dehradun Plant-IV and (II) Addition of Injectables Dosage Capability at the existing facility at Dehradun Plant - II. Funding Incremental Working Capital Requirements of the Company. Repayment/Prepayment of certain of the Borrowings. General Corporate Purposes.
Windlas Biotech Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - grievance@windlasbiotech.com
Website - www.windlasbiotech.com